Business Trends

Jan 22, 2018
By BioPharm International Editors
Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.
Jan 19, 2018
By BioPharm International Editors
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
Jan 01, 2018
BioPharm International
Recent investments show expansion activity in cell culture facilities.
Jan 01, 2018
BioPharm International
Policy makers look to boost generic drugs, curb opioid abuse, and maintain incentives for innovation.
Jan 01, 2018
BioPharm International
Gene therapies highlight FDA new drug approvals in 2017.
Jan 01, 2018
BioPharm International
BioPharm International will mark 30 years of biopharma industry progress and challenges in 2018.
Jan 01, 2018
BioPharm International
Scientific advances and renewed investment may infuse biopharma for growth.
Dec 28, 2017
By BioPharm International Editors
Roche has agreed to acquire Ignyta, an oncology company specializing in precision medicines, in an all-cash transaction valued at $1.7 billion.
Dec 28, 2017
By BioPharm International Editors
Mallinckrodt has agreed to acquire biopharmaceutical company Sucampo Pharmaceuticals for $18 per share, or a transaction value of approximately $1.2 billion.
Dec 20, 2017
New tax legislation may result in savings for biopharma companies.
native1_300x100
lorem ipsum